Reevaluating the role of calcitriol therapy in the reduction of proteinuria in children with chronic kidney disease
- PMID: 40650789
- DOI: 10.1007/s11255-025-04666-0
Reevaluating the role of calcitriol therapy in the reduction of proteinuria in children with chronic kidney disease
Keywords: Calcitriol; vitamin D; proteinuria; Pediatric; chronic kidney disease.
Conflict of interest statement
Declarations. Conflict of interest: The authors declare no competing interests.
Comment on
-
Efficacy and safety of calcitriol therapy for reduction of proteinuria in children with chronic kidney disease: an open-label randomized controlled trial.Int Urol Nephrol. 2025 Jun 29. doi: 10.1007/s11255-025-04623-x. Online ahead of print. Int Urol Nephrol. 2025. PMID: 40583089
Similar articles
-
Efficacy and safety of calcitriol therapy for reduction of proteinuria in children with chronic kidney disease: an open-label randomized controlled trial.Int Urol Nephrol. 2025 Jun 29. doi: 10.1007/s11255-025-04623-x. Online ahead of print. Int Urol Nephrol. 2025. PMID: 40583089
-
Interventions for metabolic bone disease in children with chronic kidney disease.Cochrane Database Syst Rev. 2015 Nov 12;2015(11):CD008327. doi: 10.1002/14651858.CD008327.pub2. Cochrane Database Syst Rev. 2015. PMID: 26561037 Free PMC article.
-
Interventions for bone disease in children with chronic kidney disease.Cochrane Database Syst Rev. 2010 Jan 20;(1):CD008327. doi: 10.1002/14651858.CD008327. Cochrane Database Syst Rev. 2010. Update in: Cochrane Database Syst Rev. 2015 Nov 12;(11):CD008327. doi: 10.1002/14651858.CD008327.pub2. PMID: 20091666 Updated.
-
Effects of Vitamin D Supplementation in Diabetic Kidney Disease: A Systematic Review.J Ren Nutr. 2023 Sep;33(5):618-628. doi: 10.1053/j.jrn.2023.05.006. Epub 2023 Jun 9. J Ren Nutr. 2023. PMID: 37302723
-
Interventions for chronic kidney disease in people with sickle cell disease.Cochrane Database Syst Rev. 2023 Aug 4;8(8):CD012380. doi: 10.1002/14651858.CD012380.pub3. Cochrane Database Syst Rev. 2023. PMID: 37539955 Free PMC article.
Cited by
-
Concerns about GFR estimation and one-time testing in older CKD patients.Int Urol Nephrol. 2025 Aug 12. doi: 10.1007/s11255-025-04723-8. Online ahead of print. Int Urol Nephrol. 2025. PMID: 40794351 No abstract available.
References
-
- Meena J, Thergaonkar RW, Sinha A, Lakshmy R, Bagga A, Hari P (2025) Efficacy and safety of calcitriol therapy for reduction of proteinuria in children with chronic kidney disease: an open-label randomized controlled trial. Int Urol Nephrol. https://doi.org/10.1007/s11255-025-04623-x - DOI - PubMed
-
- Webb NJA, Lerner G, Warady BA, Dell KM, Greenbaum LA, Ariceta G et al (2017) Efficacy and safety of paricalcitol in children with stages 3 to 5 chronic kidney disease. Pediatr Nephrol 32:1221–1232. https://doi.org/10.1007/s00467-017-3579-6 - DOI - PubMed - PMC
-
- Alborzi P, Patel NA, Peterson C, Bills JE, Bekele DM, Bunaye Z et al (2008) Paricalcitol reduces albuminuria and inflammation in chronic kidney disease: a randomized double-blind pilot trial. Hypertension 52:249–255. https://doi.org/10.1161/HYPERTENSIONAHA.108.113159 - DOI - PubMed
-
- Liu L-J, Lv J-C, Shi S-F, Chen Y-Q, Zhang H, Wang H-Y (2012) Oral calcitriol for reduction of proteinuria in patients with IgA nephropathy: a randomized controlled trial. Am J Kidney Dis 59:67–74. https://doi.org/10.1053/j.ajkd.2011.09.014 - DOI - PubMed
-
- de Borst MH, Hajhosseiny R, Tamez H, Wenger J, Thadhani R, Goldsmith DJA (2013) Active vitamin D treatment for reduction of residual proteinuria: a systematic review. J Am Soc Nephrol 24:1863–1871. https://doi.org/10.1681/ASN.2013030203 - DOI - PubMed - PMC
Publication types
LinkOut - more resources
Full Text Sources